The company focuses on reducing long-term complications and delivering precise treatment to the tumor bed by isolating breast tissue and improving treatment techniques. This is in response to the shift towards longer survival rates and the need to address the side effects associated with conventional treatment methods. Medical practitioners are implementing protocols to achieve better outcomes in less time.